<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05794828</url>
  </required_header>
  <id_info>
    <org_study_id>HSC20220911H</org_study_id>
    <nct_id>NCT05794828</nct_id>
  </id_info>
  <brief_title>Erector Spinae Regional Anesthesia for Pain Control</brief_title>
  <official_title>Erector Spinae Regional Anesthesia for Pain Control in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center at San Antonio</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional study to use erector spinae plane block (ESPB) on diagnoses of posterior or&#xD;
      lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and&#xD;
      back pain for multimodal pain therapy to determine its assistance with pain relief as well as&#xD;
      the patient's use of opiates after block completion&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with the listed diagnoses will be offered and then consented for an ESPB under&#xD;
      ultrasound guidance. They will rate their pain before and 30 minutes after the procedure&#xD;
      using the ordinal categorical data on a numeric pain scale. Total patient opiate use will be&#xD;
      gathered up to 8 hours after block completion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2023</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2024</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group open label assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Scale Rating</measure>
    <time_frame>Baseline to study procedure end (approximately 30 minutes)</time_frame>
    <description>Change in pain scale rating assessed by the participants on a scale from 0-10 with 0 indicating no pain and 10 indicating the most severe pain.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain Management</condition>
  <arm_group>
    <arm_group_label>Erector Spinae Plane Block (ESP) administration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Injection</intervention_name>
    <description>Bucivacaine will be administered intramuscularly according to package insert directions after first numbing the area with lidocaine subcutaneously</description>
    <arm_group_label>Erector Spinae Plane Block (ESP) administration</arm_group_label>
    <other_name>Bupivacaine Hydrochloride Injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Posterior/lateral rib or vertebral fractures&#xD;
&#xD;
          -  Pancreatitis or pancreatic cancer&#xD;
&#xD;
          -  Renal colic&#xD;
&#xD;
          -  Back pain&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unstable vitals&#xD;
&#xD;
          -  Infection or open wound over insertion site&#xD;
&#xD;
          -  Prior allergic reaction to local anesthetic&#xD;
&#xD;
          -  Pregnant females&#xD;
&#xD;
          -  Patients &lt;18 years old&#xD;
&#xD;
          -  Altered mentation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morgan Ritz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Health Science Center San Antonio</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Morgan Ritz, MD</last_name>
    <phone>972-757-2495</phone>
    <email>ritzm@uthscsa.edu</email>
  </overall_contact>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 20, 2023</study_first_submitted>
  <study_first_submitted_qc>March 20, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2023</study_first_posted>
  <last_update_submitted>March 20, 2023</last_update_submitted>
  <last_update_submitted_qc>March 20, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Erector spinae plane block</keyword>
  <keyword>ESPB</keyword>
  <keyword>Pain reduction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified data will be shared in a peer reviewed publication after acceptance by the journal</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>At study completion, after acceptance into a peer reviewed journal</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

